Kynos Therapeutics

0 followers


Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.

Employees

1-10

Links

Org chart

Scott Webster
Chief Technology Officer
Alison Strutt
Chief Financial Officer

Teams

This company has no teams yet